19 results
Thumbnail

D3.260 - Shiitake-Induced Flagellate Dermatitis: Case Series from Kazakhstan

Thumbnail

D3.261 - Orphan Diseases In Allergology - Melkersson-Rosenthal Syndrome

Thumbnail

D3.264 - Delayed Type Hypersensitivity Injection Site Reaction Induced By Liraglutide

Thumbnail

D3.265 - Gleish syndrome: A case report

Thumbnail

D3.266 - Component-Resolved Delayed Hypersensitivity to Piperacillin/Tazobactam and Clavulanic Acid Despite Structural Divergence

Thumbnail

D3.267 - Statistics of Contributing Factors to Atopic Dermatitis in Children

Thumbnail

D3.256 - A Child with Mastocytosis presenting with generalized severe Pruritus: A Diagnostic Pitfall

Thumbnail

D3.258 - Not just a rash: a delayed diagnosis of allopurinol-induced dress syndrome

Thumbnail

D3.418 - A Phase 1b Study of Lesigercept, a Long-acting High-affinity IgETrap-Fc Fusion Protein: Safety, Tolerability, PK, and PD in Atopic Healthy and Allergic Subjects

Thumbnail

D3.419 - Efficacy, safety, and remission outcomes of omalizumab in elderly patients with severe allergic asthma: a subgroup analysis by age of onset

Thumbnail

D3.420 - Real-world epidemiologic characteristics of patients treated with dupilumab for type 2 inflammatory indications: a single-center retrospective cohort study

Thumbnail

D3.421 - Real-world Effectiveness and Safety of Lanadelumab Treatment in Patients With Hereditary Angioedema: The 12-Month Interim Analysis of a Polish, Prospective, Multicenter, Observational Study (CHOPIN)

Thumbnail

D3.422 - Dupilumab in children with multimorbid atopic phenotype: therapy efficacy, safety and biomarker changes

Thumbnail

D3.423 - Lanadelumab treatment is effective and safe in patients with Factor XII associated cold-induced autoinflammatory syndrome: results from an open-label proof-of-concept study

Thumbnail

D3.424 - Retrospective Analysis of Self-Administration of Biologic Treatments for Severe Asthma and Chronic Urticaria

Thumbnail

D3.426 - Predicting response to omalizumab in patients with chronic spontaneous urticaria: The first results of the global multicenter UCARE SCOPUS project

Thumbnail

D3.427 - Challenging the paradigm: Use of omalizumab in refractory angioedema in a 2-year-old child

Thumbnail

D3.428 - Substratification of Biologic Treatment Using Dupilumab in Eosinophilic COPD

Thumbnail

D3.417 - Dupilumab in pediatric patients with severe atopic dermatitis